Bioequivalence is the absence of a significant difference in the rate and extent of absorption of the active ingredient that reaches systemic circulation (bioavailability). If products have equivalent bioavailability, it is considered they will have the same clinical effects. BA/BE Studies will be performed by well-defined systems, procedures and with regulatory compliances.
Expertise in Various Type of Studies
- Parallel, Crossover, Partial, Replicate and Full Replicate.
- Long Housing Duration & Long Washout study
- Special Population Study: Post-Menopausal Women, Geriatric
- Multiple Dose Studies
- Steady-state Studies
- PD Studies